Endpoint Clinical RTSM: Getting The Job Done — Why Doing This Well Matters

Managing investigational products (IP) in clinical trials is far more complex than simply randomizing patients or shipping supplies. It requires precision, compliance, and proactive risk mitigation to avoid delays, financial waste, and compromised data integrity. This resource reframes RTSM (Randomization and Trial Supply Management) through the Job-to-be-Done (JTBD) lens, highlighting the true objectives stakeholders aim to achieve: timely enrollment and dosing, operational confidence, and accelerated trial completion. It explores the unique challenges faced by clinical operations, site staff, and supply chain managers — such as global logistics, regulatory complexity, and usability concerns — and demonstrates how modern RTSM solutions address these pain points. Key capabilities include predictive supply forecasting, AI-driven anomaly detection, automated expiry management, and seamless integration with eClinical systems. By aligning RTSM with functional, financial, and emotional needs, organizations can reduce risk, optimize costs, and improve patient outcomes.

Access the full white paper to learn how a JTBD-driven RTSM approach transforms trial efficiency and delivers measurable ROI.